Vurdering af reguleringsmæssige behov - liste

Vurdering af reguleringsmæssige behov - liste

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 03 maj 2024. Database contains 5017 unique substances/entries.
Filter the list
Foreseen regulatory need:
Date of intention:
Date of assessment:
Latest update:

The List does not contain any Substances.
 
203-119-8
103-52-6
ECHA
Under development
Pending action
22-dec.-2023
Details
203-118-2
103-50-4
ECHA
Under development
CCH
05-mar.-2021
Details
203-117-7
103-49-1
ECHA
Under development
No action
11-jan.-2022
Details
203-116-1
103-48-0
ECHA
Under development
Pending action
22-dec.-2023
Details
203-113-5
103-45-7
ECHA
Under development
CCH
22-dec.-2023
Details
203-106-7
103-38-8
ECHA
Under development
No action
22-dec.-2023
Details
203-105-1
103-37-7
ECHA
Under development
No action
22-dec.-2023
Details
203-096-4
103-29-7
ECHA
Under development
CLH
12-jan.-2024
Details
203-095-9
103-28-6
ECHA
Under development
No action
22-dec.-2023
Details
203-091-7
103-24-2
ECHA
Under development
CCH
20-aug.-2021
Details
203-090-1
103-23-1
ECHA
Under development
CCH
20-aug.-2021
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
None
15-aug.-2017
Details
203-080-7
103-11-7
ECHA
Under development
CLH
Other action
08-jul.-2021
Details
233-667-3
10294-70-9
ECHA
Under development
No action
27-okt.-2023
Details
233-662-6
10294-54-9
ECHA
Under development
CCH
11-maj-2022
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
CLH
28-maj-2019
Details
600-351-5
10277-43-7
ECHA
Under development
Pending action
05-jul.-2021
Details
213-835-2
1026-92-2
ECHA
Under development
No action
26-jul.-2021
Details
233-593-1
10254-57-6
Germany
Bioaccumulation
Persistence
Under development
No suggestion yet
Details
233-560-1
10233-13-3
ECHA
Concluded
No action
30-jun.-2021
Details
600-299-3
102322-83-8
ECHA
Under development
No action
13-okt.-2022
Details
A product obtained by the treatment of battery scraps to recover lead. Composed primarily of oxides and sulfates of antimony and lead.
310-061-8
102110-60-1
ECHA
Under development
No action
02-apr.-2024
Details
310-060-2
102110-59-8
ECHA
Under development
No action
29-nov.-2023
Details
The residues obtained by the addition of aluminum or zinc to end liquors obtained from secondary refining of gold, iridium, osmium, palladium, platinum, rhenium, ruthenium or silver. Composed primarily of the precious metals, ammonium chloride and chlorides of aluminum, magnesium and zinc.
310-051-3
102110-50-9
ECHA
Under development
No action
02-apr.-2024
Details
310-050-8
102110-49-6
ECHA
Under development
No action
02-apr.-2024
Details
203-063-4
102-87-4
ECHA
Under development
No action
19-maj-2020
Details
203-061-3
102-85-2
ECHA
Under development
No action
17-apr.-2024
Details
203-058-7
102-82-9
ECHA
Under development
Pending action
19-maj-2020
Details
203-051-9
102-76-1
ECHA
Concluded
No action
10-nov.-2021
Details
203-049-8
102-71-6
France
Endocrine disruption
Under development
No suggestion yet
Details
203-047-7
102-69-2
ECHA
Under development
CCH
19-maj-2020
Details
203-041-4
102-60-3
ECHA
Under development
Pending action
20-okt.-2023
Details
203-026-2
102-36-3
ECHA
Under development
Pending action
16-jan.-2023
Details
203-004-2
102-08-9
ECHA
Concluded
CCH
11-jun.-2020
Details
203-002-1
102-06-7
France
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Under development
No suggestion yet
Details
203-002-1
102-06-7
France
Toxic for reproduction
Under development
No suggestion yet
Details
600-255-3
10196-18-6
ECHA
Under development
No action
17-aug.-2023
Details
600-254-8
10195-54-7
ECHA
Concluded
No action
12-jun.-2020
Details
233-477-0
10193-36-9
ECHA
CCH
17-okt.-2022
Details
AROCY M-10
405-790-4
101657-77-6
ECHA
Under development
No action
16-dec.-2021
Details
627-025-5
101541-04-2
ECHA
Concluded
No action
04-nov.-2022
Details
233-402-1
10141-05-6
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Restriction
09-jun.-2017
Details
233-401-6
10141-00-1
ECHA
Under development
Pending action
08-nov.-2023
Details
430-700-5
10138-36-0
ECHA
Under development
No action
26-feb.-2021
Details
233-334-2
10124-43-3
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Restriction
09-jun.-2017
Details
show/hide
Sulfuric acid, cadmium salt (1:1), hydrate EC / List no: 626-360-4 | CAS no: 15244-35-6
Sulfuric acid, cadmium salt, hydrate (3:3:8) EC / List no: 616-572-5 | CAS no: 7790-84-3
233-331-6
10124-36-4
Sweden
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
SVHC
23-sep.-2014
Details
309-832-1
101227-09-2
ECHA
Concluded
No action
30-jun.-2021
Details
309-831-6
101227-08-1
ECHA
Concluded
No action
30-jun.-2021
Details
600-158-6
10102-40-6
Under development
No action
11-maj-2022
Details
600-157-0
10102-25-7
ECHA
Under development
CLH
17-jan.-2022
Details

Export search results to: